Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

HoUng Kim^{1

2}, Rieke Alten³, Luisa Avedano⁴, Axel Dignass⁵, Fernando Gomollón⁶, Kay Greveson⁷, Jonas Halfvarson⁸, Peter M Irving⁹, Jørgen Jahnsen^{10

11}, Péter L Lakatos^{12

13}, JongHyuk Lee¹⁴, Souzi Makri¹⁵, Ben Parker^{16

17}, Laurent Peyrin-Biroulet¹⁸, Stefan Schreiber¹⁹, Steven Simoens²⁰, Rene Westhovens²¹, Silvio Danese^{22

23}, Ji Hoon Jeong²⁴

Affiliations

¹ Celltrion Healthcare, Incheon, Republic of Korea.
² Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
³ Department of Internal Medicine and Rheumatology, Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany.
⁴ European Federation of Crohn's and Ulcerative Colitis Associations, Brussels, Belgium.
⁵ Department of Medicine 1, Agaplesion Markus Hospital, Frankfurt am Main, Germany.
⁶ Gastroenterology Unit, Clinical University Hospital Lozano Bless IIS Aragón, Zaragoza, Spain.
⁷ Centre for Gastroenterology, Royal Free Hospital, London, UK.
⁸ Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
⁹ IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹⁰ Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.
¹¹ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
¹² Division of Gastroenterology, McGill University, Montreal, QC, Canada.
¹³ 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
¹⁴ Department of Pharmaceutical Engineering, College of Life and Health Science, Hoseo University, Asan, Republic of Korea.
¹⁵ Cyprus League Against Rheumatism, Nicosia, Cyprus.
¹⁶ Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
¹⁷ Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
¹⁸ Inflammatory Bowel Disease Unit, Nancy University Hospital, Allée du Morvan, France.
¹⁹ Department Medicine I, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
²⁰ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
²¹ Department of Development and Regeneration, Skeletal Biology and Engineering Research Center KU Leuven, Rheumatology University Hospital Leuven, Leuven, Belgium.
²² Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, IRCCS, via Manzoni 56, 20089, Rozzano, Milan, Italy. sdanese@hotmail.com.
²³ Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy. sdanese@hotmail.com.
²⁴ Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. jhjeong3@cau.ac.kr.

PMID: 32488813
PMCID: PMC7645575
DOI: 10.1007/s40265-020-01333-9

Published Erratum

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

HoUng Kim et al. Drugs. 2020 Jul.

. 2020 Jul;80(10):1039-1040.

doi: 10.1007/s40265-020-01333-9.

Authors

Affiliations

¹ Celltrion Healthcare, Incheon, Republic of Korea.
² Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
³ Department of Internal Medicine and Rheumatology, Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany.
⁴ European Federation of Crohn's and Ulcerative Colitis Associations, Brussels, Belgium.
⁵ Department of Medicine 1, Agaplesion Markus Hospital, Frankfurt am Main, Germany.
⁶ Gastroenterology Unit, Clinical University Hospital Lozano Bless IIS Aragón, Zaragoza, Spain.
⁷ Centre for Gastroenterology, Royal Free Hospital, London, UK.
⁸ Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
⁹ IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹⁰ Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.
¹¹ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
¹² Division of Gastroenterology, McGill University, Montreal, QC, Canada.
¹³ 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
¹⁴ Department of Pharmaceutical Engineering, College of Life and Health Science, Hoseo University, Asan, Republic of Korea.
¹⁵ Cyprus League Against Rheumatism, Nicosia, Cyprus.
¹⁶ Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
¹⁷ Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
¹⁸ Inflammatory Bowel Disease Unit, Nancy University Hospital, Allée du Morvan, France.
¹⁹ Department Medicine I, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
²⁰ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
²¹ Department of Development and Regeneration, Skeletal Biology and Engineering Research Center KU Leuven, Rheumatology University Hospital Leuven, Leuven, Belgium.
²² Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, IRCCS, via Manzoni 56, 20089, Rozzano, Milan, Italy. sdanese@hotmail.com.
²³ Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy. sdanese@hotmail.com.
²⁴ Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. jhjeong3@cau.ac.kr.

PMID: 32488813
PMCID: PMC7645575
DOI: 10.1007/s40265-020-01333-9

Abstract

The affiliation of the corresponding author Silvio Danese, which currently reads.

PubMed Disclaimer

Erratum for

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
Kim H, Alten R, Avedano L, Dignass A, Gomollón F, Greveson K, Halfvarson J, Irving PM, Jahnsen J, Lakatos PL, Lee J, Makri S, Parker B, Peyrin-Biroulet L, Schreiber S, Simoens S, Westhovens R, Danese S, Jeong JH. Kim H, et al. Drugs. 2020 Feb;80(2):99-113. doi: 10.1007/s40265-020-01256-5. Drugs. 2020. PMID: 32002851 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

Affiliations

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources